Get the Stockscreener App
18.75
0.91%
0.17
Pre-market:
18.61
-0.14
-0.75%
Innoviva Inc stock is traded at $18.75, with a volume of 618.94K.
It is up +0.91% in the last 24 hours and up +5.10% over the past month.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$18.58
Open:
$18.68
24h Volume:
618.94K
Relative Volume:
1.03
Market Cap:
$1.17B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
11.36
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
+6.05%
1M Performance:
+5.10%
6M Performance:
+9.08%
1Y Performance:
+15.31%
1-Day Range:
$18.66
$18.89
1-Week Range:
$17.90
$18.89
52-Week Range:
$14.32
$21.28
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
18.75 | 1.17B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
Innoviva Inc Stock (INVA) Latest News
Innoviva (NASDAQ:INVA) investors are up 4.7% in the past week, but earnings have declined over the last five years - Simply Wall St
When (INVA) Moves Investors should Listen - Stock Traders Daily
JPMorgan Chase & Co. Has $11.17 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
JPMorgan Chase & Co. Acquires 72,039 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Armata Pharmaceuticals Announces $35 Million Secured Credit Agre - GuruFocus.com
(INVA) Trading Report - Stock Traders Daily
Principal Financial Group Inc. Cuts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Downgraded to “Hold” Rating by StockNews.com - Defense World
Innoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.com - MarketBeat
Barclays PLC Purchases 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Geode Capital Management LLC Has $26.22 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Barclays PLC Acquires 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Trading (INVA) With Integrated Risk Controls - Stock Traders Daily
Stock Gains You Can't Ignore! - Jomfruland.net
Innoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five years - Yahoo Finance
MML Investors Services LLC Buys 2,985 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Jane Street Group LLC - Defense World
Jane Street Group LLC Increases Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Fmr LLC Buys 771 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Wellington Management Group LLP Sells 42,739 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by HighTower Advisors LLC - Defense World
Innoviva, Inc.'s (NASDAQ:INVA) Popularity With Investors Is Under Threat From Overpricing - Simply Wall St
Oversold Conditions For Innoviva (INVA) - Nasdaq
Innoviva, Inc. (NASDAQ:INVA) Short Interest Down 7.5% in November - Defense World
Innoviva enters distribution, license agreement with Basilea for Zevtera - Yahoo Finance
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole) - BioSpace
Innoviva seals deal for new MRSA antibiotic in the US - Investing.com
Innoviva seals deal for new MRSA antibiotic in the US By Investing.com - Investing.com UK
Innoviva Secures Exclusive Rights to Groundbreaking MRSA Antibiotic Zevtera in Major FDA-Approved Drug Deal - StockTitan
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States - The Manila Times
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera(R) (ceftobiprole) in the United States - Marketscreener.com
Basilea announces agreement with Innoviva Specialty - GlobeNewswire
Basilea Announces Agreement with Innoviva Specialty Therapeutics for the Commercialization of Antibiotic Zevtera (Ceftobiprole) in the United States - Marketscreener.com
How To Trade (INVA) - Stock Traders Daily
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 22,961 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Walleye Capital LLC Purchases Shares of 11,066 Innoviva, Inc. (NASDAQ:INVA) - Defense World
Charles Schwab Investment Management Inc. Reduces Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Charles Schwab Investment Management Inc. Has $14.14 Million Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Systematic Financial Management LP Increases Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Redwood Investment Management LLC Sells 41,852 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Thrivent Financial for Lutherans Sells 2,384 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva to Participate in the Citi 2024 Global Healthcare Conference - BioSpace
Innoviva, Inc. (NASDAQ:INVA) Stake Reduced by Westfield Capital Management Co. LP - MarketBeat
Segall Bryant & Hamill LLC Makes New $715,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Victory Capital Management Inc. Grows Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Jennison Associates LLC - MarketBeat
Pacer Advisors Inc. Sells 547,610 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Principal Financial Group Inc. Sells 20,058 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Empowered Funds LLC Has $1.85 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Innoviva Reports Strong Q3 Growth Amidst Strategic Advances - TipRanks
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):